We are live on ! Find out more

Chemed

CHE

Market cap $6.79B

519.84 USD

-4.61

0.88%

At close Updated Sep 4, 4:00 PM EDT

Pre-market

After hours

518.50

-1.34

0.26%

1 day

-0.88%

5 days

-0.48%

1 month

-3.68%

3 months

20.24%

6 months

26.48%

Year to date

22.66%

1 year

13.08%

5 years

12.02%

10 years

278.12%

About: Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Employees: 15,811

Healthcare Medical Care Facilities

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 38.9%

Neutral 55.6%

Negative 5.6%

The Motley Fool

Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040

The sale occurred on Aug. 21 and was valued at approximately $541,000. The disposition reduced the executive's direct equity holdings by 7%.

Chemed Executive Spencer Lee Sells 1,000 Shares for $541,040

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE

NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE

Zacks Investment Research

Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?

Zacks Investment Research

OPCH or CHE: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Option Care (OPCH) or Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?

OPCH or CHE: Which Is the Better Value Stock Right Now?

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE

NEW YORK--(BUSINESS WIRE)---- $CHE #NYSE--Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Chemed Corporation (NYSE: CHE) failed to manage Chemed in an acceptable manner, breaching their fiduciary duties to Chemed, and whether Chemed and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know: On August 13, 2026, The Capital Forum released a report alleging t.

CHEMED CORPORATION INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Chemed Corporation's Directors and Officers for Breach of Fiduciary Duties – CHE

Chemed Corporation Declares Quarterly Dividend of 70 Cents

CINCINNATI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on September 3, 2026, to shareholders of record as of August 17, 2026. This is a 10-cent, or 17%, increase over the 60-cent dividend paid in June 2026.

Chemed Corporation Declares Quarterly Dividend of 70 Cents

Zacks Investment Research

AVAH vs. CHE: Which Stock Should Value Investors Buy Now?

Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the better value opportunity right now?

AVAH vs. CHE: Which Stock Should Value Investors Buy Now?

Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value

Chemed Corporation (CHE) receives a Buy rating with a $632/share target, driven by activist pressure for a spin-off to eliminate the conglomerate discount. VITAS has successfully reengineered its patient mix, sharply reducing Medicare Cap penalties and driving 8.8% revenue growth and 18.2% Adjusted EBITDA margin in Q2. Roto-Rooter faces structural margin pressure from rising digital marketing costs, but B2B expansion and operational efficiencies are expected to support future growth.

Chemed Corporation: Why A Spin-Off Could Unlock Its Hidden Value

Zacks Investment Research

Why Chemed (CHE) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Why Chemed (CHE) is a Top Momentum Stock for the Long-Term

Chemed Q2 Earnings Call Highlights

Chemed NYSE: CHE reported second-quarter 2026 results marked by stronger-than-expected performance at its VITAS hospice business, while Roto-Rooter delivered revenue growth but continued to face higher customer-acquisition costs.

Chemed Q2 Earnings Call Highlights

See News Rankings

Price charts implemented using Lightweight Charts™